You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Cocaine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


US Patents and Regulatory Information for cocaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Noden Pharma GOPRELTO cocaine hydrochloride SOLUTION;NASAL 209963-001 Dec 14, 2017 RX Yes Yes 11,040,032 ⤷  Subscribe Y ⤷  Subscribe
Noden Pharma GOPRELTO cocaine hydrochloride SOLUTION;NASAL 209963-001 Dec 14, 2017 RX Yes Yes 10,231,961 ⤷  Subscribe Y ⤷  Subscribe
Omnivium Pharms NUMBRINO cocaine hydrochloride SOLUTION;NASAL 209575-001 Jan 10, 2020 RX Yes Yes 10,149,843 ⤷  Subscribe ⤷  Subscribe
Noden Pharma GOPRELTO cocaine hydrochloride SOLUTION;NASAL 209963-001 Dec 14, 2017 RX Yes Yes 10,857,095 ⤷  Subscribe ⤷  Subscribe
Omnivium Pharms NUMBRINO cocaine hydrochloride SOLUTION;NASAL 209575-001 Jan 10, 2020 RX Yes Yes 9,867,815 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Cocaine Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Cocaine

Global Production and Supply

The global cocaine market has experienced a significant surge in recent years, particularly following the COVID-19 pandemic. According to the Global Report on Cocaine 2023 by the United Nations Office on Drugs and Crime (UNODC), coca cultivation increased by 35% from 2020 to 2021, marking a record high and the sharpest year-to-year increase since 2016[1][5].

This growth is attributed to both the expansion of coca bush cultivation and improvements in the conversion process from coca bush to cocaine hydrochloride. The total global production of cocaine reached nearly 2,000 tons in 2021, a dramatic increase from less than half of this amount in 2014[1][5].

Demand and Consumption

The rise in supply has been matched by a steady increase in demand. Most regions have shown a consistent rise in the number of cocaine users over the past decade, with the Americas and parts of Europe remaining the primary consumer markets. However, there is a growing potential for the cocaine market to expand in Africa and Asia[1][4].

Trafficking Routes and Networks

Cocaine trafficking has become increasingly diversified, with new hubs and routes emerging. Countries in Southeastern Europe and Africa, particularly West and Central Africa, are being used as key transit zones. Ports on the North Sea, such as Antwerp, Rotterdam, and Hamburg, have become significant entry points for cocaine into Western Europe, eclipsing traditional entry points in Spain and Portugal[1].

The criminal landscape has fragmented into numerous trafficking networks, including local actors, ex-FARC guerrillas, and foreign groups from Mexico and Europe. Specialized "service providers" that offer services at all stages of the supply chain for a fee have also proliferated[1].

Financial Impact on Users

Cocaine use is financially crippling for many users. The drug is expensive, and users often spend a significant portion of their income on it. Crack cocaine, while cheaper, leads to drug binges and massive financial losses. Users frequently engage in risky or illegal activities to fund their habit, which can result in legal troubles, fines, and extended sentences[2].

Legal and Health Costs

The financial burden of cocaine use extends beyond the cost of the drug itself. Users are more likely to encounter legal issues, including arrests for possession or distribution, which can lead to lifelong impacts. Legal fees, fines, and the time spent serving sentences further exacerbate the financial difficulties[2].

Market for Cocaine Use Disorder Treatment

The market for treating cocaine use disorder is growing, driven by increased awareness and social acceptance of addiction issues. The global market was estimated at USD 1.32 billion in 2023 and is expected to grow at a CAGR of 6.21% to reach USD 2.01 billion by 2030. This growth is fueled by governmental and private funding for addiction treatment programs, advancements in treatment methodologies, and the increasing prevalence of cocaine use worldwide[3].

However, challenges such as the limited availability of specialized healthcare providers, social stigmas associated with drug addiction, and regulatory hurdles may limit the adoption of treatment options. Innovations like personalized medicine approaches and the use of artificial intelligence and machine learning in treatment are expected to drive significant growth in the market[3].

Global Seizures and Interdiction

Despite the rise in production and demand, law enforcement efforts have also intensified. Cocaine seizures reached a record high of nearly 2,000 tons in 2021, indicating that interdiction efforts have been effective in containing the growth of the global amount of cocaine available for consumption[1][5].

Regional Insights

Western and Central Europe constitute the second-largest cocaine consumer market globally, after North America. The region has seen a stable prevalence rate of cocaine use between 2010 and 2019, with significant seizures reported in countries like Colombia, the United States, Brazil, Panama, and Belgium[4].

Cultural and Economic Context

In countries where coca cultivation is concentrated, such as Bolivia, Colombia, and Peru, coca leaves have a significant cultural role. Some cultivation is permitted to supply licit domestic markets and international manufacturers, complicating efforts to control cocaine production[4].

Key Takeaways

  • Record High Production: Global cocaine production has reached record levels, driven by increased coca cultivation and improved conversion processes.
  • Diversified Trafficking: New hubs and routes, including Southeastern Europe and Africa, are emerging, and the criminal landscape is fragmenting.
  • Financial Burden: Cocaine use is financially devastating for users, leading to legal issues, health costs, and significant financial losses.
  • Growing Treatment Market: The market for treating cocaine use disorder is expanding, driven by increased awareness and advancements in treatment methodologies.
  • Effective Interdiction: Law enforcement efforts have resulted in record-high seizures, containing the growth of available cocaine.

FAQs

Q: What has been the trend in global cocaine production in recent years?

A: Global cocaine production has seen a dramatic increase, with coca cultivation rising by 35% from 2020 to 2021, and total production reaching nearly 2,000 tons in 2021[1][5].

Q: How has the COVID-19 pandemic affected the cocaine market?

A: The pandemic initially disrupted the cocaine market by curtailing international travel and closing nightclubs and bars, but the market has since rebounded, with supply and demand returning to pre-pandemic levels[5].

Q: What are the financial implications of cocaine use for individuals?

A: Cocaine use can lead to significant financial losses, legal troubles, and health costs. Users often spend a large portion of their income on the drug and may engage in risky activities to fund their habit[2].

Q: Which regions are emerging as new hubs for cocaine trafficking?

A: Countries in Southeastern Europe and Africa, particularly West and Central Africa, are increasingly being used as key transit zones for cocaine trafficking[1].

Q: How is the market for treating cocaine use disorder evolving?

A: The market is growing due to increased awareness, social acceptance, and advancements in treatment methodologies. It is expected to reach USD 2.01 billion by 2030, driven by governmental and private funding and innovative treatment approaches[3].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.